Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Nature Immunology|April 26, 2016
IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungsSuzanne M Bal, Jochem H Bernink, Maho Nagasawa, et al.
Clinical and Translational Allergy|January 5, 2018
European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases: report of the European Union Parliament Summit (29 March 2017)Peter W Hellings, David Borrelli, Sirpa Pietikainen, et al.
Allergy|October 19, 2020
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paperLudger Klimek, Marek Jutel, Jean Bousquet, et al.
Frontiers in Allergy|June 30, 2022
White Paper on European Patient Needs and Suggestions on Chronic Type 2 Inflammation of Airways and Skin by EUFOREALouise De Prins, Ulrike Raap, Tara Mueller, et al.
The Journal of Allergy and Clinical Immunology|March 8, 2016
Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkersPeter Tomassen, Griet Vandeplas, Thibaut Van Zele, et al.
Frontiers in Allergy|September 26, 2022
Corrigendum on: White paper on European patient needs and suggestions on chronic type 2 inflammation of airways and skin by EUFOREALouise De Prins, Ulrike Raap, Tara Mueller, et al.
Clinical and Translational Allergy|January 8, 2020
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paperValerie Hox, Evelijn Lourijsen, Arnout Jordens, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 7, 2020
Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases WorkshopRobert Naclerio, Fuad Baroody, Claus Bachert, et al.
Clinical and Translational Allergy|October 2, 2020
Correction to: Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paperValerie Hox, Evelijn Lourijsen, Arnout Jordens, et al.
Allergy|April 21, 2026
Meta-Analysis on the Harm of Systemic Glucocorticosteroids in Inflammatory Upper Airway Disease and Asthma: An EAACI Task ForceSophie Scheire, Evelijn Lourijsen, Manon Blauwblomme, et al.
Pageof 7